Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinoma

View ORCID ProfileLucía Trilla-Fuertes, Natalia Miranda, Daniel Castellano, Rocío López-Vacas, Carlos A. Farfán Tello, Guillermo de Velasco, Felipe Villacampa, Elena López-Camacho, Guillermo Prado-Vázquez, Andrea Zapater-Moros, Enrique Espinosa, View ORCID ProfileJuan Ángel Fresno Vara, Álvaro Pinto, Angelo Gámez-Pozo
doi: https://doi.org/10.1101/2019.12.12.19014696
Lucía Trilla-Fuertes
1Biomedica Molecular Medicine SL, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lucía Trilla-Fuertes
Natalia Miranda
2Urology Service, Hospital Universitario 12 de Octubre, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Castellano
3Medical Oncology Service, Hospital Universitario 12 de Octubre, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rocío López-Vacas
4Molecular Oncology and Pathology Lab, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos A. Farfán Tello
3Medical Oncology Service, Hospital Universitario 12 de Octubre, Madrid, Spain
5Medical Director sede San Isidro, Clínica Internacional S.A., Lima, Perú
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guillermo de Velasco
3Medical Oncology Service, Hospital Universitario 12 de Octubre, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Felipe Villacampa
6Urology Department, Clínica Universidad de Navarra, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena López-Camacho
1Biomedica Molecular Medicine SL, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guillermo Prado-Vázquez
1Biomedica Molecular Medicine SL, Madrid, Spain
4Molecular Oncology and Pathology Lab, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Zapater-Moros
1Biomedica Molecular Medicine SL, Madrid, Spain
4Molecular Oncology and Pathology Lab, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain
7Biomedical Research Networking Center on Oncology-CIBERONC, ISCIII, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Enrique Espinosa
7Biomedical Research Networking Center on Oncology-CIBERONC, ISCIII, Madrid, Spain
8Medical Oncology Service, La Paz University Hospital-IdiPAZ, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan Ángel Fresno Vara
1Biomedica Molecular Medicine SL, Madrid, Spain
4Molecular Oncology and Pathology Lab, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain
7Biomedical Research Networking Center on Oncology-CIBERONC, ISCIII, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Juan Ángel Fresno Vara
Álvaro Pinto
8Medical Oncology Service, La Paz University Hospital-IdiPAZ, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: alvaropintomarin{at}gmail.com angelogamez{at}gmail.com
Angelo Gámez-Pozo
1Biomedica Molecular Medicine SL, Madrid, Spain
4Molecular Oncology and Pathology Lab, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: alvaropintomarin{at}gmail.com angelogamez{at}gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Data Availability

All relevant data are included as supplementary files.

Back to top
PreviousNext
Posted December 15, 2019.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinoma
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinoma
Lucía Trilla-Fuertes, Natalia Miranda, Daniel Castellano, Rocío López-Vacas, Carlos A. Farfán Tello, Guillermo de Velasco, Felipe Villacampa, Elena López-Camacho, Guillermo Prado-Vázquez, Andrea Zapater-Moros, Enrique Espinosa, Juan Ángel Fresno Vara, Álvaro Pinto, Angelo Gámez-Pozo
medRxiv 2019.12.12.19014696; doi: https://doi.org/10.1101/2019.12.12.19014696
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinoma
Lucía Trilla-Fuertes, Natalia Miranda, Daniel Castellano, Rocío López-Vacas, Carlos A. Farfán Tello, Guillermo de Velasco, Felipe Villacampa, Elena López-Camacho, Guillermo Prado-Vázquez, Andrea Zapater-Moros, Enrique Espinosa, Juan Ángel Fresno Vara, Álvaro Pinto, Angelo Gámez-Pozo
medRxiv 2019.12.12.19014696; doi: https://doi.org/10.1101/2019.12.12.19014696

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)